Summary

for people ages 22 months to 26 months (full criteria)
at San Diego, California and other locations
study started
estimated completion

Description

Summary

An extension of the PREMOD2 trial, the PREMOD2 Follow-Up trial will evaluate the neurodevelopmental outcomes at 22-26 months corrected age of preterm children who received UCM or DCC.

Official Title

Two Year Developmental Follow-up for Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2

Details

The PREMOD2 Follow-up trial will examine the difference in early childhood neurodevelopmental impairment of subjects enrolled in the PREMOD2 umbilical cord milking (UCM) vs. delayed cord clamping (DCC) trial, using standardized neurologic and developmental assessments at 22-26 months corrected age.

Keywords

Neurodevelopmental Abnormality Neurodevelopmental impairment, prematurity Disability Umbilical cord milking Delayed cord clamping Premature Birth Congenital Abnormalities Randomized to Umbilical Cord Milking at birth Randomized to Delayed Cord Clamping at birth

Eligibility

You can join if…

Open to people ages 22 months to 26 months

  • Children enrolled in the PREMOD2 non-inferiority trial at birth who survive to 2 years corrected age.

You CAN'T join if...

  • Children enrolled in the PREMOD2 non-inferiority trial at birth who did not survive or are lost to follow-up.

Locations

  • Sharp Mary Birch Hospital for Women and Newborns accepting new patients
    San Diego California 92123 United States
  • Sharp Grossmont Hospital accepting new patients
    San Diego California 91942 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Sharp HealthCare
ID
NCT03476980
Study Type
Interventional
Last Updated